Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hazard

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Plastic and Reconstructive Surgery|October 12, 2005
Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experienceAndrew L Greensmith, Bruce R Johnstone, Susan M Reid, et al.
Presse Medicale (Paris, France : 1983)|October 27, 1984
[Does blood ferritin permit diagnosis of iron deficiency in Basedow's disease?]J C Rymer, I Rozenberg, F Galacteros, et al.
Presse Medicale (Paris, France : 1983)|October 12, 1985
[Insulinoma: diagnostic elements. 13 cases]J Hazard, D Simon, L Perlemuter, et al.
Annales D'Endocrinologie|May 1, 1974
[Our attitude towards the treatment of thyroid cancer (a report of 50 cases ) (author's transl)]D Mellière, J Hazard, P Galle, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort studyCorey Langer, Arliene Ravelo, Sebastien J Hazard, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2008
Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimatorLisa J Hazard, Brian Wang, Thomas B Skidmore, et al.
Drugs - Real World Outcomes|October 18, 2016
First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community PracticesOrsolya E Lunacsek, Arliene Ravelo, Anna D Coutinho, et al.
American Journal of Clinical Oncology|January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak TrialsCorey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2016
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort studyLarry Leon, Michael Kosty, Mohammad Jahanzeb, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2015
Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort studyA J Wozniak, M P Kosty, M Jahanzeb, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Plastic and Reconstructive Surgery|October 12, 2005
Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experienceAndrew L Greensmith, Bruce R Johnstone, Susan M Reid, et al.
Presse Medicale (Paris, France : 1983)|October 27, 1984
[Does blood ferritin permit diagnosis of iron deficiency in Basedow's disease?]J C Rymer, I Rozenberg, F Galacteros, et al.
Presse Medicale (Paris, France : 1983)|October 12, 1985
[Insulinoma: diagnostic elements. 13 cases]J Hazard, D Simon, L Perlemuter, et al.
Annales D'Endocrinologie|May 1, 1974
[Our attitude towards the treatment of thyroid cancer (a report of 50 cases ) (author's transl)]D Mellière, J Hazard, P Galle, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort studyCorey Langer, Arliene Ravelo, Sebastien J Hazard, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2008
Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimatorLisa J Hazard, Brian Wang, Thomas B Skidmore, et al.
Drugs - Real World Outcomes|October 18, 2016
First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community PracticesOrsolya E Lunacsek, Arliene Ravelo, Anna D Coutinho, et al.
American Journal of Clinical Oncology|January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak TrialsCorey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2016
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort studyLarry Leon, Michael Kosty, Mohammad Jahanzeb, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2015
Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort studyA J Wozniak, M P Kosty, M Jahanzeb, et al.
Pageof 10